NASDAQ NMS - GLOBAL MARKET · CNTX
-0.42% · -$0.0021 · Vol Not reported
Pre-market · updated 04:05:48 ET
Context Therapeutics Inc

Context Therapeutics Inc

Pharmaceuticals
$0.4980
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
CNTX
Context Therapeutics Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CNTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CNTX catalysts
About Context Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
15
Country
US

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.5001
Last session
Day high
$0.5001
Last session
Day low
$0.5001
Last session
Previous close
$0.5001
52W high
$3.36
-85.18% from high
52W low
$0.4523
2% of range
Market cap
$45.9M
EPS
$-0.4300
Beta
-0.41
Shares out
91.9M
Avg volume
1.9M
VWAP
$0.5001
Last session
Price history computed in-house
1W
-6.09%
1M
-18.91%
3M
-81.06%
1Y
-44.23%
YTD
-66.12%
SMA 50 $0.6199 · below
SMA 200 $1.67 · below
52W position 2%

CNTX overview

Veridion Score
45
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CNTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CNTX Form 4 filings
Public disclosures

Congress activity in CNTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CNTX in the cached public ledger.

Federal contracts

CNTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CNTX in this window.
Lobbying spend

CNTX lobbying filings, year to date.

Registered lobbying filings matched to Context Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CNTX in this window.
Loading news for CNTX
Analyst ratings
Sovereign unlock shows live analyst consensus for CNTX.
Options
Sovereign unlock shows live options positioning for CNTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.